BMS marks 70 years in Australia with renewed commitment to innovation and access

December 11, 2025 Latest News BioPharma

This is a preview of subscriber content

Subscribe now to continue reading.

“Having viewed healthcare policy from the benches of Parliament in the UK, I have a unique appreciation for what a 70-year partnership between an innovator like BMS and a nation like Australia truly represents,” said General Manager Owen Smith …

Subscribe now to continue reading.

Latest Video

Health Department clarifies PBAC plan after confusion over paediatric access to biologics
December 10, 2025 - Latest News
If this was the plan, why wasn't it included in the response to questions last week?
December 10, 2025 - Latest News
Regulators approve longevity molecule NMN for use in therapeutic goods
December 9, 2025 - Latest News
Immutep strikes major licensing deal with Dr. Reddy’s to commercialise novel cancer immunotherapy
December 9, 2025 - Australian Biotech
Australian breakthrough uncovers genetic trigger for severe macular degeneration
December 9, 2025 - Australian Biotech

BMS marks 70 years in Australia with renewed commitment to innovation and access

This is a preview of subscriber content

Latest Video

Most Read

Health Department clarifies PBAC plan after confusion over paediatric access to biologics

If this was the plan, why wasn't it included in the response to questions last week?

Regulators approve longevity molecule NMN for use in therapeutic goods

Immutep strikes major licensing deal with Dr. Reddy’s to commercialise novel cancer immunotherapy

Australian breakthrough uncovers genetic trigger for severe macular degeneration

New Stories

Medicines Australia gains a new voice with Vertex joining the association

BMS marks 70 years in Australia with renewed commitment to innovation and access

Opportunity cost is a moral and ethical question when it involves travel, tickets, or treating sick children

Pfizer’s high-stakes sprint to build momentum in century-defining market

Mayne Pharma rejects Cosette’s attempt to terminate scheme deal

TGA clears the way for LTR Pharma’s Phase 2 Study of SPONTAN

OncoSil announces first UK patient treated with its pancreatic cancer treatment

Sign In

BMS marks 70 years in Australia with renewed commitment to innovation and access

This is a preview of subscriber content

Latest Video

Most Read

Health Department clarifies PBAC plan after confusion over paediatric access to biologics

If this was the plan, why wasn't it included in the response to questions last week?

Regulators approve longevity molecule NMN for use in therapeutic goods

Immutep strikes major licensing deal with Dr. Reddy’s to commercialise novel cancer immunotherapy

Australian breakthrough uncovers genetic trigger for severe macular degeneration

Follow Us

New Stories

Medicines Australia gains a new voice with Vertex joining the association

BMS marks 70 years in Australia with renewed commitment to innovation and access

Opportunity cost is a moral and ethical question when it involves travel, tickets, or treating sick children

Pfizer’s high-stakes sprint to build momentum in century-defining market

Mayne Pharma rejects Cosette’s attempt to terminate scheme deal

TGA clears the way for LTR Pharma’s Phase 2 Study of SPONTAN

OncoSil announces first UK patient treated with its pancreatic cancer treatment